brompheniramine maleate 0.266 MG/ML / codeine phosphate 1.27 MG/ML / phenylephrine hydrochloride 0.666 MG/ML Oral Solution [M-End PE]

RxCUI
1244921
RxNorm name
brompheniramine maleate 0.266 MG/ML / codeine phosphate 1.27 MG/ML / phenylephrine hydrochloride 0.666 MG/ML Oral Solution [M-End PE]
Display name
M-END PE (Oral Liquid)
Full name
brompheniramine maleate 0.266 MG/ML / codeine phosphate 1.27 MG/ML / phenylephrine hydrochloride 0.666 MG/ML Oral Solution [M-End PE]
Term type
SBD
Status
Active
Strength
1.33-6.35-3.33 mg/5ml
Dose form
Sol
Route
Oral Liquid
Updated
2026-08-01 06:52:51

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032012
Active start
032012
Multiple ingredient
YES
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
brompheniramine maleate0.266 MG / 1 MLbrompheniraminebrompheniramine maleate
codeine phosphate1.27 MG / 1 MLcodeinecodeine phosphate
phenylephrine hydrochloride0.666 MG / 1 MLphenylephrinephenylephrine hydrochloride

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Solution316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
brompheniramine1767
codeine2670
phenylephrine8163

Source Vocabulary Codes#

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 2 matching rows.

NDC11, Source, Active table
NDC11SourceActive
12830075412rxnav_ndcsyes
12830075430rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
fce1a6e4-cda3-462e-a853-049eabe4441eM-END PER.A. McNeil Company20221215

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC01CAAdrenergic and dopaminergic agentsATC1-4phenylephrine
ATCR05DAOpium alkaloids and derivativesATC1-4codeine
ATCC05AXOther agents for treatment of hemorrhoids and anal fissures for topical useATC1-4phenylephrine
ATCR06ABSubstituted alkylaminesATC1-4brompheniramine
ATCR01BASympathomimeticsATC1-4phenylephrine
ATCS01FBSympathomimetics excl. antiglaucoma preparationsATC1-4phenylephrine
ATCS01GASympathomimetics used as decongestantsATC1-4phenylephrine
ATCR01ABSympathomimetics, combinations excl. corticosteroidsATC1-4phenylephrine
ATCR01AASympathomimetics, plainATC1-4phenylephrine
FDASPLN0000186105alpha-1 Adrenergic AgonistEPChas_epcphenylephrine
MEDRTD001977BrompheniramineCHEMhas_ingredientbrompheniramine maleate
MEDRTD001977BrompheniramineCHEMhas_ingredientbrompheniramine
MEDRTD003061CodeineCHEMhas_ingredientcodeine phosphate
MEDRTD003061CodeineCHEMhas_ingredientcodeine
MEDRTD009020MorphineCHEMhas_active_metabolitescodeine phosphate
MEDRTD009020MorphineCHEMhas_active_metabolitescodeine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine
MEDRTD010656PhenylephrineCHEMhas_ingredientphenylephrine hydrochloride
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine
MEDRTD013447SulfitesCHEMci_chemclassphenylephrine hydrochloride
MEDRTD001249AsthmaDISEASEci_withcodeine phosphate
MEDRTD001249AsthmaDISEASEci_withcodeine
MEDRTD003139Common ColdDISEASEmay_treatbrompheniramine maleate
MEDRTD003139Common ColdDISEASEmay_treatbrompheniramine
MEDRTD003327Coronary DiseaseDISEASEci_withbrompheniramine maleate
MEDRTD003327Coronary DiseaseDISEASEci_withbrompheniramine
MEDRTD003371CoughDISEASEmay_treatcodeine
MEDRTD003371CoughDISEASEmay_treatcodeine phosphate
MEDRTD004342Drug HypersensitivityDISEASEci_withcodeine
MEDRTD004342Drug HypersensitivityDISEASEci_withbrompheniramine
MEDRTD004342Drug HypersensitivityDISEASEci_withbrompheniramine maleate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine
MEDRTD004342Drug HypersensitivityDISEASEci_withcodeine phosphate
MEDRTD004342Drug HypersensitivityDISEASEci_withphenylephrine hydrochloride
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine hydrochloride
MEDRTD005401Fissure in AnoDISEASEmay_treatphenylephrine
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withbrompheniramine maleate
MEDRTD015812Glaucoma, Angle-ClosureDISEASEci_withbrompheniramine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine
MEDRTD005902Glaucoma, Open-AngleDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine hydrochloride
MEDRTD006484HemorrhoidsDISEASEmay_treatphenylephrine
MEDRTD006973HypertensionDISEASEci_withphenylephrine
MEDRTD006973HypertensionDISEASEci_withbrompheniramine
MEDRTD006973HypertensionDISEASEci_withbrompheniramine maleate
MEDRTD006973HypertensionDISEASEci_withphenylephrine hydrochloride
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine hydrochloride
MEDRTD007022HypotensionDISEASEmay_treatphenylephrine
MEDRTD007415Intestinal ObstructionDISEASEci_withcodeine
MEDRTD007415Intestinal ObstructionDISEASEci_withbrompheniramine maleate
MEDRTD007415Intestinal ObstructionDISEASEci_withcodeine phosphate
MEDRTD007415Intestinal ObstructionDISEASEci_withbrompheniramine
MEDRTD015878MydriasisDISEASEinducesphenylephrine
MEDRTD015878MydriasisDISEASEinducesphenylephrine hydrochloride
MEDRTD010146PainDISEASEmay_treatcodeine phosphate
MEDRTD010146PainDISEASEmay_treatcodeine
MEDRTD010437Peptic UlcerDISEASEci_withbrompheniramine maleate
MEDRTD010437Peptic UlcerDISEASEci_withbrompheniramine
MEDRTD011247PregnancyDISEASEci_withcodeine phosphate
MEDRTD011247PregnancyDISEASEci_withcodeine
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine hydrochloride
MEDRTD011538Pruritus AniDISEASEmay_treatphenylephrine
MEDRTD012131Respiratory InsufficiencyDISEASEci_withcodeine phosphate
MEDRTD012131Respiratory InsufficiencyDISEASEci_withcodeine
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatbrompheniramine maleate
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treatbrompheniramine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatbrompheniramine
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatbrompheniramine maleate
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012223Rhinitis, VasomotorDISEASEmay_treatphenylephrine
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine hydrochloride
MEDRTD012772Shock, SepticDISEASEmay_treatphenylephrine
MEDRTD013224Status AsthmaticusDISEASEci_withbrompheniramine
MEDRTD013224Status AsthmaticusDISEASEci_withbrompheniramine maleate
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine
MEDRTD013617Tachycardia, SupraventricularDISEASEmay_treatphenylephrine hydrochloride
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine
MEDRTD017180Tachycardia, VentricularDISEASEci_withphenylephrine hydrochloride
MEDRTD014517Ureteral ObstructionDISEASEci_withbrompheniramine
MEDRTD014517Ureteral ObstructionDISEASEci_withbrompheniramine maleate
MEDRTD014522Urethral DiseasesDISEASEci_withbrompheniramine maleate
MEDRTD014522Urethral DiseasesDISEASEci_withbrompheniramine
MEDRTD014581UrticariaDISEASEmay_treatbrompheniramine maleate
MEDRTD014581UrticariaDISEASEmay_treatbrompheniramine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine
MEDRTN0000000209Adrenergic alpha-AgonistsMOAhas_moaphenylephrine hydrochloride
MEDRTN0000175684Full Opioid AgonistsMOAhas_moacodeine
MEDRTN0000175684Full Opioid AgonistsMOAhas_moacodeine phosphate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moabrompheniramine maleate
MEDRTN0000000190Histamine H1 Receptor AntagonistsMOAhas_moabrompheniramine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacodeine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moabrompheniramine
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moabrompheniramine maleate
MEDRTN0000000184Monoamine Oxidase InhibitorsMOAci_moacodeine phosphate
MEDRTN0000175439AnalgesiaPEhas_pecodeine
MEDRTN0000175439AnalgesiaPEhas_pecodeine phosphate
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine
MEDRTN0000008371Conjunctival Arterial VasoconstrictionPEhas_pephenylephrine hydrochloride
MEDRTN0000008383Decreased Acetylcholine ActivityPEhas_pebrompheniramine maleate
MEDRTN0000008383Decreased Acetylcholine ActivityPEhas_pebrompheniramine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pebrompheniramine
MEDRTN0000008657Decreased Histamine ActivityPEhas_pebrompheniramine maleate
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pecodeine phosphate
MEDRTN0000008701Decreased Medullary Respiratory DrivePEhas_pecodeine
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine
MEDRTN0000008896Decreased Nasal and Sinus SecretionsPEhas_pephenylephrine hydrochloride
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pecodeine phosphate
MEDRTN0000008768Decreased Organized Electrical ActivityPEhas_pecodeine
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismcodeine phosphate
MEDRTN0000000026Hepatic MetabolismPKhas_pkcodeine phosphate
MEDRTN0000000026Hepatic MetabolismPKsite_of_metabolismcodeine
MEDRTN0000000026Hepatic MetabolismPKhas_pkcodeine
MEDRTN0000000042Renal ExcretionPKhas_pkcodeine phosphate
MEDRTN0000000042Renal ExcretionPKhas_pkcodeine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.266 MG/ML / 1.27 MG/ML / 0.666 MG/ML
ATTRIBUTESGENERAL_CARDINALITYMULTI
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESTTYSBD
CODESMMSL_CODEBD24964
CODESRxCUI1244921
NAMESPrescribable SynonymM-End PE 6.33 MG / 1.33 MG / 3.33 MG in 5 mL Oral Solution
NAMESRXNAV_STRM-End PE (brompehiramine maleate 1.33 MG / codeine phosphate 6.33 MG / phenylephrine hydrochloride 3.33 MG) per 5 ML Oral Solution
NAMESRxNorm Namebrompheniramine maleate 0.266 MG/ML / codeine phosphate 1.27 MG/ML / phenylephrine hydrochloride 0.666 MG/ML Oral Solution [M-End PE]
NAMESRxNorm SynonymM-End PE (brompehiramine maleate 1.33 MG / codeine phosphate 6.33 MG / phenylephrine hydrochloride 3.33 MG) per 5 ML Oral Solution
NAMESRxNorm SynonymM-End PE (codeine phosphate 6.33 MG / brompehiramine maleate 1.33 MG / phenylephrine hydrochloride 3.33 MG) per 5 ML Oral Solution
SOURCESSourceGold Standard Alchemy